0113 343 8407
Summary: I lead the LICAP Pathology and Tumour Biology section, and the Colorectal Cancer Group.
Location: Wellcome Trust Brenner Building 4.20a
Teaching Commitments: BMS, LSM (2nd year MBChB module), RESS, MRes, ESREP
Phil Quirke has an active research group in bowel cancer as well as being the Academic Training Programme Director for West Yorkshire and the Chair of the NHS Bowel Cancer Screening Programme Pathology Committee.
His major interests are in bowel cancer. The first YCR programme concentrates on (i) quality of surgery and multidisciplinary treatment (ii) response to therapy in clinical trials in colorectal cancer contributing to the pathology and molecular pathology assessments (iii) screening and the development of early neoplastic lesions. The second YCR programme is directed at improving outcomes in colorectal cancer in Yorkshire and the Humber. The CRUK programme lead by Professor John Ladbury is aimed at understanding cancer of non-genetic origin. I am part of the digital pathology group lead by Dr Darren Treanor in collaboration with computing within the University of Leeds with interests in 3 Dimensional histopathology and genotype phenotype integration. We are using molecular testing to choose targeted therapies in the MRC Focus 4 trial and are part of the national SCORT network trying to discover new molecular markers.
We collaborate with international colleagues in the Karolinska Hospital, Stockholm, University of Erlangen, University of Aarhus, Denmark, Tokyo University, Cancer Hospital Chennai India. Phil is an Honorary Fellow of the American College of Colon and Rectal Surgeons, the Association of Coloproctology of Great Britain and Ireland, the Societad de Coloproctology Chile and has received the McKeown and Miles medals. He chairs the NHS Bowel Cancer Screening Programme and undertakes pathology screening research. He is an NIHR Senior Investigator and a Fellow of the Academy of Medical Sciences.